Topics We Track

Remote verification, workforce capacity, pharmacist accountability, and the regulation shaping rural and at-scale pharmacy.

• Remote verification and the pharmacist of record
• Workforce capacity and burnout
• DEA and state telepharmacy rules
• Workflow redesign at scale

Implementation, scaling, ROI, governance, and the operating-model changes behind healthcare AI that actually ships.

• Moving from pilot to production
• Measuring ROI that survives the CFO
• Governance and accountability
• The EHR bottleneck

Decision support, automation bias, human oversight, and clinician deskilling at the point of care.

• Clinical decision support and alert fatigue
• Automation bias and deskilling
• Ambient documentation
• Human oversight and patient safety

Scientific exchange, field medical, evidence generation, and how AI is reshaping the work between pharma and the clinicians who read it.

• Scientific exchange and MSL workflow
• Evidence generation and real-world evidence
• Medical communications and publication integrity
• KOL engagement and field intelligence

FDA, CMS, OIG, and state pharmacy law, plus the enforcement and compliance implications for operators.

• FDA device and CDS guidance
• CMS payment and prior authorization rules
• OIG and fraud enforcement
• State pharmacy and prescribing law